Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product-Reference-Cited by-同舟云学术

Non-viral ocular gene therapy, pEYS606, for the treatment of non-infectious uveitis: Preclinical evaluation of the medicinal product

Published:2018-09 Issue: Volume:285 Page:244-251
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Touchard Elodie,Benard Romain,Bigot Karine,Laffitte Jean-Denis,Buggage Ronald,Bordet Thierry,Behar-Cohen Francine

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference36 articles.

1. Guidance on Noncorticosteroid Systemic Immunomodulatory Therapy in Noninfectious Uveitis: Fundamentals Of Care for UveitiS (FOCUS) Initiative;Dick;Ophthalmology,2018

2. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial;Nguyen;Lancet,2016

3. Intravitreal anti-VEGF injections for treating wet age-related macular degeneration: a systematic review and meta-analysis;Ba;Drug Des. Devel. Ther.,2015

4. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia;Zhu;Cochrane Database Syst. Rev.,2016

5. Therapies for macular edema associated with central retinal vein occlusion: a report by the American Academy of Ophthalmology;Yeh;Ophthalmology,2015

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on non-infectious uveitis treatment: anti-TNF-alpha and beyond;Frontiers in Ophthalmology;2024-08-02

2. What’s New in Ocular Drug Delivery: Advances in Suprachoroidal Injection since 2023;Pharmaceuticals;2024-07-30

3. Exploring precision treatments in immune‐mediated inflammatory diseases: Harnessing the infinite potential of nucleic acid delivery;Exploration;2024-05-24

4. Seeing the Future: A Review of Ocular Therapy;Bioengineering;2024-02-13

5. AAV2 and AAV9 tropism and transgene expression in the mouse eye and major tissues after intravitreal and subretinal delivery;Frontiers in Drug Delivery;2023-07-12